AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Drug: ketorolac
Target: Serine/threonine-protein kinase PAK 1 (Kinase)
Gene: PAK1
UniProt: Q13153 (PAK1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.44
Assay: Inhibition of PAK1 in human A549 cells using myelin basic protein as substrate preincubated for 24 hrs followed by PAK1 immunoprecipation and substrate addition measured after 60 mins by ATP-Glo kinase assay
Drug: ketotifen
Target: D(1A) dopamine receptor (GPCR)
Gene: DRD1
UniProt: P21728 (DRD1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.361
Assay: DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390)
Drug: ketotifen
Target: Alpha-2A adrenergic receptor (GPCR)
Gene: ADRA2A
UniProt: P08913 (ADA2A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.086
Assay: DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug: ketotifen
Target: Multidrug resistance protein 1 (Transporter)
Gene: ABCB1
UniProt: P08183 (MDR1_HUMAN)
Organism: Homo sapiens
Drug: ketotifen
Target: 5-hydroxytryptamine receptor 1A (GPCR)
Gene: HTR1A
UniProt: P08908 (5HT1A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.839
Assay: DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT)
Drug: ketotifen
Target: 5-hydroxytryptamine receptor 2A (GPCR)
Gene: HTR2A
UniProt: P28223 (5HT2A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.047
Assay: DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin)
Drug: ketotifen
Target: 5-hydroxytryptamine receptor 2B (GPCR)
Gene: HTR2B
UniProt: P41595 (5HT2B_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.538
Assay: DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide)
Drug: ketotifen
Target: 5-hydroxytryptamine receptor 2C (GPCR)
Gene: HTR2C
UniProt: P28335 (5HT2C_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.076
Assay: DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine)
Drug: ketotifen
Target: 5-hydroxytryptamine receptor 6 (GPCR)
Gene: HTR6
UniProt: P50406 (5HT6R_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.276
Assay: DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide)
Drug: ketotifen
Target: Alpha-2B adrenergic receptor (GPCR)
Gene: ADRA2B
UniProt: P18089 (ADA2B_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.489
Assay: DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug: ketotifen
Target: D(3) dopamine receptor (GPCR)
Gene: DRD3
UniProt: P35462 (DRD3_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.176
Assay: DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone)
Drug: ketotifen
Target: Histamine H1 receptor (GPCR)
Gene: HRH1
UniProt: P35367 (HRH1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 9.509
Action type: ANTAGONIST
Drug: ketotifen
Target: Histamine H2 receptor (GPCR)
Gene: HRH2
UniProt: P25021 (HRH2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.391
Assay: DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine)
Drug: ketotifen
Target: Histamine H4 receptor (GPCR)
Gene: HRH4
UniProt: Q9H3N8 (HRH4_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.68
Assay: Histamine H-4 Receptor Binding Assay: Histamine H-4 Receptor Binding Assay
Drug: ketotifen
Target: Muscarinic acetylcholine receptor M1 (GPCR)
Gene: CHRM1
UniProt: P11229 (ACM1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.016
Drug: ketotifen
Target: Muscarinic acetylcholine receptor M2 (GPCR)
Gene: CHRM2
UniProt: P08172 (ACM2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.359
Drug: ketotifen
Target: Muscarinic acetylcholine receptor M3 (GPCR)
Gene: CHRM3
UniProt: P20309 (ACM3_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.577
Drug: ketotifen
Target: Muscarinic acetylcholine receptor M4 (GPCR)
Gene: CHRM4
UniProt: P08173 (ACM4_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.075
Drug: ketotifen
Target: Muscarinic acetylcholine receptor M5 (GPCR)
Gene: CHRM5
UniProt: P08912 (ACM5_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.73
Drug: ketotifen
Target: Alpha-1D adrenergic receptor (GPCR)
Gene: ADRA1D
UniProt: P25100 (ADA1D_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.737
Assay: DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin)
Drug: ketotifen
Target: Histamine H1 receptor (GPCR)
Gene: HRH1
UniProt: P31389 (HRH1_CAVPO)
Organism: Cavia porcellus
Activity: Ki = 9.51
Assay: The compound was tested in vitro for binding affinity against histamine H1 receptor from guinea pig cerebellum, using [3H]pyrilamine as radioligand at 0.1 uM
Drug: ketotifen
Target: 5-hydroxytryptamine receptor 1A (GPCR)
Gene: Htr1a
UniProt: P19327 (5HT1A_RAT)
Organism: Rattus norvegicus
Activity: IC50 = 5.6
Drug: labetalol
Target: Beta-1 adrenergic receptor (GPCR)
Gene: ADRB1
UniProt: P08588 (ADRB1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.234
Action type: ANTAGONIST
Assay: DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug: labetalol
Target: Beta-2 adrenergic receptor (GPCR)
Gene: ADRB2
UniProt: P07550 (ADRB2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.959
Action type: ANTAGONIST
Assay: DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)
Drug: labetalol
Target: Sigma non-opioid intracellular receptor 1 (Membrane receptor)
Gene: SIGMAR1
UniProt: Q99720 (SGMR1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.117
Assay: DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol)
Drug: labetalol
Target: Sodium-dependent noradrenaline transporter (Transporter)
Gene: SLC6A2
UniProt: P23975 (SC6A2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.478
Assay: DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55)
Drug: labetalol
Target: 5-hydroxytryptamine receptor 1A (GPCR)
Gene: HTR1A
UniProt: P08908 (5HT1A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.648
Assay: DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT)
Drug: labetalol
Target: 5-hydroxytryptamine receptor 2B (GPCR)
Gene: HTR2B
UniProt: P41595 (5HT2B_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.714
Assay: DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide)
Drug: labetalol
Target: Sodium-dependent dopamine transporter (Transporter)
Gene: SLC6A3
UniProt: Q01959 (SC6A3_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.894
Assay: DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55)
Drug: labetalol
Target: Cytochrome P450 2D6 (Enzyme)
Gene: CYP2D6
UniProt: P10635 (CP2D6_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6.097
Assay: DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)
Drug: labetalol
Target: Alpha-1D adrenergic receptor (GPCR)
Gene: ADRA1D
UniProt: P25100 (ADA1D_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.638
Action type: ANTAGONIST
Assay: DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin)
Drug: labetalol
Target: Alpha-1B adrenergic receptor (GPCR)
Gene: Adra1b
UniProt: P15823 (ADA1B_RAT)
Organism: Rattus norvegicus
Activity: Ki = 6.491
Assay: DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin)
Drug: labetalol
Target: Alpha-1A adrenergic receptor (GPCR)
Gene: Adra1a
UniProt: P43140 (ADA1A_RAT)
Organism: Rattus norvegicus
Activity: IC50 = 7.24
Drug: labetalol
Target: 5-hydroxytryptamine receptor 1A (GPCR)
Gene: Htr1a
UniProt: P19327 (5HT1A_RAT)
Organism: Rattus norvegicus
Activity: IC50 = 6.41
Drug: labetalol
Target: CAAX prenyl protease 1 (Enzyme)
Gene: STE24
UniProt: P47154 (STE24_YEAST)
Organism: Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
Activity: AC50 = 5.11
Assay: Active
Drug: labetalol
Target: CAAX prenyl protease 2 (Enzyme)
Gene: RCE1
UniProt: Q03530 (RCE1_YEAST)
Organism: Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
Activity: AC50 = 4.82
Assay: Active
Drug: lacidipine
Target: Cytochrome P450 3A4 (Enzyme)
Gene: CYP3A4
UniProt: P08684 (CP3A4_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6.046
Assay: DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)
Drug: lacidipine
Target: Sodium-dependent noradrenaline transporter (Transporter)
Gene: SLC6A2
UniProt: P23975 (SC6A2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.245
Assay: DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55)
Drug: lacidipine
Target: D(3) dopamine receptor (GPCR)
Gene: DRD3
UniProt: P35462 (DRD3_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.679
Assay: DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone)
Drug: lacidipine
Target: Adenosine receptor A3 (GPCR)
Gene: ADORA3
UniProt: P0DMS8 (AA3R_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.642
Assay: DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)
Drug: lacidipine
Target: Cytochrome P450 2C9 (Enzyme)
Gene: CYP2C9
UniProt: P11712 (CP2C9_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.699
Assay: DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)
Drug: lacidipine
Target: Cytochrome P450 2C19 (Enzyme)
Gene: CYP2C19
UniProt: P33261 (CP2CJ_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.699
Assay: DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)
Drug: lacidipine
Target: Thromboxane-A synthase (Enzyme)
Gene: TBXAS1
UniProt: P24557 (THAS_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.771
Assay: DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2)
Drug: lacidipine
Target: Androgen receptor (Transcription factor)
Gene: Ar
UniProt: P15207 (ANDR_RAT)
Organism: Rattus norvegicus
Activity: Ki = 5.583
Assay: DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone)
Drug: lacidipine
Target: Voltage-gated L-type calcium channel (Ion channel)
Gene: CACNA1D|CACNA1C
UniProt: Q01668|Q13936 (CAC1D_HUMAN|CAC1C_HUMAN)
Organism: Homo sapiens
Action type: BLOCKER
Assay: Mechanism of Action
Drug: lactose
Target: Galectin-8 (Unclassified)
Gene: LGALS8
UniProt: O00214 (LEG8_HUMAN)
Organism: Homo sapiens
Activity: Kd = 4.21
Assay: Binding affinity to galectin 8N terminal domain at 20 degC by fluorescence polarization assay
Drug: lactose
Target: Galectin-9 (Unclassified)
Gene: LGALS9
UniProt: O00182 (LEG9_HUMAN)
Organism: Homo sapiens
Activity: Kd = 4.64
Assay: Binding affinity to galectin 9N terminal domain at 0 degC by fluorescence polarization assay
Drug: lactose
Target: Galectin-3 (Unclassified)
Gene: LGALS3
UniProt: P17931 (LEG3_HUMAN)
Organism: Homo sapiens
Activity: Kd = 4.03
Drug: lamivudine
Target: Deoxycytidine kinase (Kinase)
Gene: DCK
UniProt: P27707 (DCK_HUMAN)
Organism: Homo sapiens
Drug: lamivudine
Target: Protein P (Polyprotein)
Gene: P
UniProt: Q9IF40 (Q9IF40_HBV)
Organism: Hepatitis B virus
Action type: INHIBITOR
Assay: Mechanism of Action; CHEMBL2362994; SINGLE PROTEIN
Drug: lamivudine
Target: Reverse transcriptase/RNaseH (Enzyme)
Gene: pol
UniProt: Q72547 (Q72547_9HIV1)
Organism: Human immunodeficiency virus 1
Activity: EC50 = 7.38
Action type: INHIBITOR
Assay: In vitro antiviral activity against HIV-1 Reverse transcriptase wild type
Drug: lamotrigine
Target: Sodium channel protein type 5 subunit alpha (Ion channel)
Gene: SCN5A
UniProt: Q14524 (SCN5A_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.21
Action type: BLOCKER
Assay: Inhibition of human recombinant Nav1.5 channel expressed in HEK293 cells by whole cell voltage clamp technique
Drug: lamotrigine
Target: Sigma non-opioid intracellular receptor 1 (Membrane receptor)
Gene: SIGMAR1
UniProt: Q99720 (SGMR1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 3.839
Drug: lamotrigine
Target: Sodium channel protein type 1 subunit alpha (Ion channel)
Gene: SCN1A
UniProt: P35498 (SCN1A_HUMAN)
Organism: Homo sapiens
Action type: BLOCKER
Drug: lamotrigine
Target: Sodium channel protein type 2 subunit alpha (Ion channel)
Gene: SCN2A
UniProt: Q99250 (SCN2A_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5
Action type: BLOCKER
Assay: Inhibition of human recombinant Nav1.2 channel expressed in HEK293 cells by whole cell voltage clamp technique
Drug: lamotrigine
Target: Sodium channel protein type 3 subunit alpha (Ion channel)
Gene: SCN3A
UniProt: Q9NY46 (SCN3A_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.77
Action type: BLOCKER
Assay: Inhibition of human Nav1.3 expressed in SHSY5Y cells assessed as reduction in blue fluorescent signal by VSP-FRET assay
Drug: lamotrigine
Target: Sodium channel protein type 4 subunit alpha (Ion channel)
Gene: SCN4A
UniProt: P35499 (SCN4A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 4.77
Action type: BLOCKER
Assay: Affinity for inactive human SkM1 sodium channel expressed in HEK293 cells
Drug: lamotrigine
Target: Sodium channel protein type 8 subunit alpha (Ion channel)
Gene: SCN8A
UniProt: Q9UQD0 (SCN8A_HUMAN)
Organism: Homo sapiens
Action type: BLOCKER
Drug: lamotrigine
Target: Sodium channel protein type 9 subunit alpha (Ion channel)
Gene: SCN9A
UniProt: Q15858 (SCN9A_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.77
Action type: BLOCKER
Assay: Inhibition of human Nav1.7 expressed in SHSY5Y cells assessed as reduction in blue fluorescent signal by VSP-FRET assay
Drug: lamotrigine
Target: 5-hydroxytryptamine receptor 3A (Ion channel)
Gene: HTR3A
UniProt: P46098 (5HT3A_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.744
Drug: lamotrigine
Target: Sodium channel protein type 10 subunit alpha (Ion channel)
Gene: SCN10A
UniProt: Q9Y5Y9 (SCNAA_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.02
Action type: BLOCKER
Assay: Inhibition of human recombinant Nav1.8 channel expressed in HEK293 cells by whole cell voltage clamp technique
Drug: lamotrigine
Target: Sodium channel protein type 2 subunit alpha (Ion channel)
Gene: Scn2a
UniProt: P04775 (SCN2A_RAT)
Organism: Rattus norvegicus
Activity: IC50 = 4.46
Assay: Inhibition of rat Nav1.2 channel expressed in chinese hamster CHL1610 cells at preconditioning pulse of -67 mV after 2 to 3 mins by whole-cell patch-clamp technique
Drug: lamotrigine
Target: Dihydrofolate reductase (Enzyme)
Gene: dfrA17
UniProt: B0BL08 (B0BL08_ECOLX)
Organism: Escherichia coli
Activity: Ki = 4.82
Assay: Inhibition of Escherichia coli DHFR assessed as NADP formation by quadratic Morrison plot analysis
Drug: lamotrigine
Target: Sodium channel alpha subunits; brain (Types I, II, III) (Ion channel)
Gene: Scn1a|Scn2a|Scn3a
UniProt: P04774|P04775|P08104 (SCN1A_RAT|SCN2A_RAT|SCN3A_RAT)
Organism: Rattus norvegicus
Activity: IC50 = 4.51
Assay: Concentration required to inhibit [3H]BTX binding to Sodium channel of rat brain
Drug: lamotrigine
Target: Sodium channel protein type X alpha subunit (Ion channel)
Gene: Scn10a
UniProt: Q62968 (SCNAA_RAT)
Organism: Rattus norvegicus
Activity: IC50 = 4.6
Assay: Blockade of Nav1.8 channel in rat dorsal root ganglion neurons assessed as inhibition of TTX-R current by whole cell patch clamp technique
Drug: landiolol
Target: Beta-1 adrenergic receptor (GPCR)
Gene: ADRB1
UniProt: P08588 (ADRB1_HUMAN)
Organism: Homo sapiens
Action type: ANTAGONIST
Drug: lanreotide
Target: Somatostatin receptor type 2 (GPCR)
Gene: SSTR2
UniProt: P30874 (SSR2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 9.6
Action type: AGONIST
Drug: lanreotide
Target: Somatostatin receptor type 3 (GPCR)
Gene: SSTR3
UniProt: P32745 (SSR3_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8
Action type: AGONIST
Drug: lanreotide
Target: Somatostatin receptor type 5 (GPCR)
Gene: SSTR5
UniProt: P35346 (SSR5_HUMAN)
Organism: Homo sapiens
Activity: Ki = 9.3
Action type: AGONIST
Drug: lanreotide
Target: Somatostatin receptor type 2 (GPCR)
Gene: Sstr2
UniProt: P30875 (SSR2_MOUSE)
Organism: Mus musculus
Activity: Ki = 9.1
Action type: AGONIST
Drug: lanreotide
Target: Somatostatin receptor type 3 (GPCR)
Gene: Sstr3
UniProt: P30935 (SSR3_MOUSE)
Organism: Mus musculus
Activity: IC50 = 8.2
Action type: AGONIST
Drug: lanreotide
Target: Somatostatin receptor type 4 (GPCR)
Gene: SSTR4
UniProt: P31391 (SSR4_HUMAN)
Organism: Homo sapiens
Activity: Ki  7.18
Drug: lanreotide
Target: Somatostatin receptor type 5 (GPCR)
Gene: Sstr5
UniProt: P30938 (SSR5_RAT)
Organism: Rattus norvegicus
Activity: Ki = 7.6
Action type: AGONIST
Drug: lanreotide
Target: Somatostatin receptor type 1 (GPCR)
Gene: SSTR1
UniProt: P30872 (SSR1_HUMAN)
Organism: Homo sapiens
Activity: Ki  6.301
Drug: lanreotide
Target: Somatostatin receptor type 2 (GPCR)
Gene: Sstr2
UniProt: P30680 (SSR2_RAT)
Organism: Rattus norvegicus
Activity: Ki = 8.8
Action type: AGONIST
Drug: lanreotide
Target: Somatostatin receptor type 3 (GPCR)
Gene: Sstr3
UniProt: P30936 (SSR3_RAT)
Organism: Rattus norvegicus
Activity: Ki = 6.9
Action type: AGONIST
Drug: lansoprazole
Target: Cytochrome P450 2D6 (Enzyme)
Gene: CYP2D6
UniProt: P10635 (CP2D6_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.275
Assay: DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)
Drug: lansoprazole
Target: Cytochrome P450 2C19 (Enzyme)
Gene: CYP2C19
UniProt: P33261 (CP2CJ_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6.473
Assay: DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)
Drug: lansoprazole
Target: Fatty acid synthase (Enzyme)
Gene: FASN
UniProt: P49327 (FAS_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.28
Drug: lansoprazole
Target: Phosphoethanolamine/phosphocholine phosphatase (Enzyme)
Gene: PHOSPHO1
UniProt: Q8TCT1 (PHOP1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6.36
Assay: PUBCHEM_BIOASSAY: SAR assay for compounds that inhibit PHOSPHO1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1545, AID1565, AID1574]
Drug: lansoprazole
Target: Microtubule-associated protein tau (Structural)
Gene: MAPT
UniProt: P10636 (TAU_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.6
Assay: Binding affinity to heparin induced human Tau 441 at 50 pM to 500 nM after 30 mins
Drug: lansoprazole
Target: Indoleamine 2,3-dioxygenase 2 (Enzyme)
Gene: Ido2
UniProt: Q8R0V5 (I23O2_MOUSE)
Organism: Mus musculus
Activity: IC50 = 5.09
Assay: Inhibition of mouse Ido2 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis
Drug: lansoprazole
Target: Potassium-transporting ATPase (Transporter)
Gene: ATP4A|ATP4B
UniProt: P20648|P51164 (ATP4A_HUMAN|ATP4B_HUMAN)
Organism: Homo sapiens
Action type: INHIBITOR
Assay: Mechanism of Action; CHEMBL2095173; PROTEIN COMPLEX
Drug: lansoprazole
Target: Indoleamine 2,3-dioxygenase 1 (Enzyme)
Gene: Ido1
UniProt: P28776 (I23O1_MOUSE)
Organism: Mus musculus
Activity: IC50 = 4.03
Assay: Inhibition of mouse Ido1 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis
Drug: lansoprazole
Target: N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (Enzyme)
Gene: DDAH1
UniProt: O94760 (DDAH1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.29
Assay: Inhibition of recombinant human DDAH1 expressed in Escherichia coli BL21 Star (DE3) using ADMA as substrate assessed as decrease in citrulline production after 4 hrs by colorimetric method
Drug: lansoprazole
Target: Cytosolic endo-beta-N-acetylglucosaminidase (Enzyme)
Gene: ENGASE
UniProt: Q8NFI3 (ENASE_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.61
Assay: Inhibition of recombinant human C-MYC/DDK-tagged ENGase expressed in HEK293T cells using heat inactivated bovine ribonuclease B as substrate pretreated for 15 mins followed by substrate addition after 90 mins by SDS-PAGE analysis
Drug: lapatinib
Target: Multidrug resistance protein 1 (Transporter)
Gene: ABCB1
UniProt: P08183 (MDR1_HUMAN)
Organism: Homo sapiens
Drug: lapatinib
Target: ATP-binding cassette sub-family G member 2 (Transporter)
Gene: ABCG2
UniProt: Q9UNQ0 (ABCG2_HUMAN)
Organism: Homo sapiens
Drug: lapatinib
Target: Platelet-derived growth factor receptor beta (Kinase)
Gene: PDGFRB
UniProt: P09619 (PGFRB_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.07
Assay: Inhibition of PDGFRbeta by flash plate based radioactive enzyme assay
Drug: lapatinib
Target: Tyrosine-protein kinase ABL1 (Kinase)
Gene: ABL1
UniProt: P00519 (ABL1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.64
Assay: Inhibition of ABL1 by flash plate based radioactive enzyme assay
Drug: lapatinib
Target: Epidermal growth factor receptor (Kinase)
Gene: EGFR
UniProt: P00533 (EGFR_HUMAN)
Organism: Homo sapiens
Activity: Kd = 9.04
Action type: INHIBITOR
Assay: Binding constant for EGFR(G719C) kinase domain
Drug: lapatinib
Target: Receptor tyrosine-protein kinase erbB-2 (Kinase)
Gene: ERBB2
UniProt: P04626 (ERBB2_HUMAN)
Organism: Homo sapiens
Activity: Kd = 8.15
Action type: INHIBITOR
Assay: Binding constant for ERBB2 kinase domain
Drug: lapatinib
Target: Solute carrier organic anion transporter family member 1B1 (Transporter)
Gene: SLCO1B1
UniProt: Q9Y6L6 (SO1B1_HUMAN)
Organism: Homo sapiens
Drug: lapatinib
Target: Cyclin-dependent kinase 2 (Kinase)
Gene: CDK2
UniProt: P24941 (CDK2_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.96
Assay: Inhibition of CDK2 by flash plate based radioactive enzyme assay
Drug: lapatinib
Target: Insulin receptor (Kinase)
Gene: INSR
UniProt: P06213 (INSR_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.77
Action type: AGONIST
Assay: Inhibition of INSR by flash plate based radioactive enzyme assay
Drug: lapatinib
Target: Receptor tyrosine-protein kinase erbB-4 (Kinase)
Gene: ERBB4
UniProt: Q15303 (ERBB4_HUMAN)
Organism: Homo sapiens
Activity: Kd = 7.27
Assay: Binding constant for ERBB4 kinase domain
Drug: lapatinib
Target: Serine/threonine-protein kinase 10 (Kinase)
Gene: STK10
UniProt: O94804 (STK10_HUMAN)
Organism: Homo sapiens
Activity: Kd = 5.59
Assay: Average Binding Constant for STK10; NA=Not Active at 10 uM
Drug: lapatinib
Target: Receptor-interacting serine/threonine-protein kinase 2 (Kinase)
Gene: RIPK2
UniProt: O43353 (RIPK2_HUMAN)
Organism: Homo sapiens
Activity: Kd = 5.44
Assay: Binding constant for RIPK2 kinase domain
Drug: lapatinib
Target: STE20-like serine/threonine-protein kinase (Kinase)
Gene: SLK
UniProt: Q9H2G2 (SLK_HUMAN)
Organism: Homo sapiens
Activity: Kd = 5.48
Assay: Binding constant for SLK kinase domain
Drug: lapatinib
Target: Dual specificity mitogen-activated protein kinase kinase 7 (Kinase)
Gene: MAP2K7
UniProt: O14733 (MP2K7_HUMAN)
Organism: Homo sapiens
Activity: Kd = 5.36
Assay: Binding constant for MKK7 kinase domain
Drug: lapatinib
Target: Tubulin alpha-1A chain (Structural)
Gene: Tuba1a
UniProt: P68370 (TBA1A_RAT)
Organism: Rattus norvegicus
Activity: Kd = 7.27
Assay: Binding constant for ERBB4 kinase domain
Drug: lapatinib
Target: Receptor tyrosine-protein kinase erbB-3 (Kinase)
Gene: ERBB3
UniProt: P21860 (ERBB3_HUMAN)
Organism: Homo sapiens
Activity: Kd = 5.26
Assay: Binding constant for ERBB3 kinase domain
Drug: lapatinib
Target: Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (Kinase)
Gene: PIK3C2B
UniProt: O00750 (P3C2B_HUMAN)
Organism: Homo sapiens
Activity: Kd = 6.17
Assay: Binding constant for PIK3C2B kinase domain
Drug: lapatinib
Target: Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma (Kinase)
Gene: PIK3C2G
UniProt: O75747 (P3C2G_HUMAN)
Organism: Homo sapiens
Activity: Kd = 5.12
Assay: Binding constant for PIK3C2G kinase domain
Drug: lapatinib
Target: Phosphatidylinositol 4-kinase beta (Kinase)
Gene: PI4KB
UniProt: Q9UBF8 (PI4KB_HUMAN)
Organism: Homo sapiens
Activity: Kd = 6.03
Assay: Binding constant for PIK4CB kinase domain
Drug: lapatinib
Target: Dual specificity mitogen-activated protein kinase kinase 5 (Kinase)
Gene: MAP2K5
UniProt: Q13163 (MP2K5_HUMAN)
Organism: Homo sapiens
Activity: Kd = 5.96
Assay: Binding constant for MEK5 kinase domain
Drug: arginine hydrochloride
Target: Nitric oxide synthase, inducible (Enzyme)
Gene: NOS2
UniProt: P35228 (NOS2_HUMAN)
Organism: Homo sapiens
Activity: Kd = 5.15
Assay: Binding affinity to truncated iNOS construct (1-490) by spectral assay
Drug: arginine hydrochloride
Target: G-protein coupled receptor family C group 6 member A (GPCR)
Gene: GPRC6A
UniProt: Q5T6X5 (GPC6A_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 4.4
Action type: AGONIST
Drug: aspartic acid
Target: Calcium-binding mitochondrial carrier protein Aralar1 (Transporter)
Gene: SLC25A12
UniProt: O75746 (CMC1_HUMAN)
Organism: Homo sapiens